Sign in

    Doug Weiss

    Research Analyst at DSW Investment

    Douglas S. Weiss, CFA, is the Founder and Managing Principal at DSW Investment, LLC, specializing in value investing across equities and fixed income for individuals and pension clients. He has covered and conducted research on companies such as S&W Seed Company, The Glimpse Group, Shuttle Pharma, SenesTech, Peraso Inc., Reliq Health Technologies, Dyadic International, Arianne Phosphate, and Syra Health Corp, with a disciplined focus on small cap stocks, corporate bonds, REITs, and closed-end funds. Weiss began his career over 19 years ago as an equity research analyst at Salomon Brothers and CIBC World Markets, later working in private wealth management at Foster & Foster, LLC, before founding DSW Investment in 2011. A Chartered Financial Analyst (CFA) and Registered Investment Advisor, he maintains FINRA registration and brings extensive expertise in security analysis, portfolio construction, and asset valuation.

    Doug Weiss's questions to MIL leadership

    Doug Weiss's questions to MIL leadership • Q3 2015

    Question

    Doug Weiss of DSW Investment inquired about the performance of the supply chain business, the strategic goal of the banking initiative, associated credit risks, and the plan for the discontinued Wabush asset.

    Answer

    CEO Gerardo Cortina acknowledged that the supply chain business was affected by the struggling steel industry, leading to a focus on cost and working capital reduction. He and CFO Sam Morrow explained the banking initiative aims to offer financial services to their existing customer base to improve margins, not just to invest cash. Morrow added that credit risk in factoring would be mitigated with additional protection and that the Wabush asset rationalization is pending the conclusion of CCAA proceedings.

    Ask Fintool Equity Research AI